Hawryluk P. Kent bought MBX
February 2, 2026 · Form 4 insider transaction
Hawryluk P. Kent bought 164,500 shares of MBX Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
164,500
Price
$0.00
Total value
N/A
InsiderHawryluk P. Kent
RoleOfficer, Director
CompanyMBX Biosciences, Inc. (MBX)
SecurityStock option (right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 2, 2026
Filing dateFebruary 3, 2026
Shares owned after164,500
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares underlying this option vest and become exercisable in forty eight (48) equal monthly installments, beginning on March 2, 2026, subject to the Reporting Person's continued service on such vesting date.